IBA Molecular has successfully completed its acquisition of Mallinckrodt Nuclear Imaging, announced in August 2016, following the receipt of regulatory approvals.
Each year imaging system manufacturers use the Radiological Society of North America (RSNA) meeting at the end of the year to unveil their latest technologies. RSNA 2016 included several new cardiovascular imaging advancements.
January 27, 2017 — Market intelligence firm Infiniti Research released a new report on the growth of 3-D mammography (tomosynthesis) in the United States, highlighting the benefits and acknowledging the barriers to continued adoption.
Mevion Medical Systems and UF Health Cancer Center - Orlando Health recently announced the first patient treatment on a Mevion S250 proton therapy system in conjunction with Airo, a mobile, diagnostic computed tomography (CT) scanner. The advanced 3D CT-based localization is integrated to Verity Patient Positioning System, a component of the Mevion S250 Series, and is based on high-precision stereotactic localization and tracking technology. This solution improves treatment accuracy and reduces patient positioning uncertainties.
Researchers have developed the first sensor capable of objectively identifying inflammatory bowel disease (IBD) and distinguishing between its two subtypes. The device represents a substantial achievement toward a more personalized approach to diagnosing and treating IBD, a chronic inflammation of the gastrointestinal tract affecting more than 1 million Americans.
Gamma Medica recently announced that through its collaboration with Ohio-based Alpha Imaging, Indiana-based Major Health Partners (MHP) has purchased and installed Gamma Medica’s LumaGEM molecular breast imaging (MBI) system. It is the state’s first LumaGEM and the hospital’s first MBI.
Siemens Healthineers has announced the expansion of its online learning platform PEPconnect (Personalized Education Plan) to include approximately 1,000 new learning modules for medical imaging customers. Effective immediately, physicians and medical technology assistants can use PEPconnect to access training courses on Siemens Healthineers systems for imaging and minimally invasive therapy in seven different languages: English, German, French, Italian, Spanish, Korean and Japanese.
Accuray Inc. announced recently that Miami Cancer Institute, a part of Baptist Health South Florida, is now treating patients using the new Radixact Treatment Delivery System, fully integrated with the new Accuray Precision Treatment Planning System and iDMS Data Management System.
